Be prepared to get the most out of your consultation
At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Dr Susan O’Brien, Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer, advises patie...
Author: PatientPowerEU
Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2016 Category: Cancer & Oncology Source Type: podcasts
How can referral to a major cancer centre dedicated to AML care affect outcomes?
At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Dr Susan O’Brien, Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer, talks about t...
Author: PatientPowerEU
Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2016 Category: Cancer & Oncology Source Type: podcasts
How can patients help with the management of their acute leukaemia?
At the American Society of Hematology (ASH) 2015 Annual Meeting held in Orlando FL., Dr Daver from the University of Texas MD Anderson Cancer Center, Houston, TX, provides guidance to patients that wa...
Author: PatientPowerEU
Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2016 Category: Cancer & Oncology Source Type: podcasts
How to approach your doctor with questions regarding the treatment of acute leukaemias
Dr Naval Daver from the University of Texas MD Anderson Cancer Center, Houston, TX, provides advice on how to approach your doctor with questions regarding your treatment and the options available to ...
Author: PatientPowerEU
Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2016 Category: Cancer & Oncology Source Type: podcasts
Overview of new combinaton therapies in acute myeloid leukaemia (AML)
At the American Society of Hematology (ASH) 2015 Annual Meeting, held in Orlando, FL., Dr Naval Daver from the University of Texas MD Anderson Cancer Center, Houston, TX, provides an overview of new c...
Author: VJHemOnc
Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts
" Camo Fish " -- The Discovery Files
A team led by researchers at The University of Texas at Austin have solved a longstanding mystery about how some fish seem to disappear from predators in the open waters of the ocean, a discovery that could help materials scientists and military technologists create more effective methods of ocean camouflage. (Source: The Discovery Files)
Source: The Discovery Files - December 17, 2015 Category: Science Authors: National Science Foundation Source Type: podcasts
RESONATE-2 Trial Results Most Likely To Move Ibrutinib to Frontline in 2016
Nitin Jain, M.D. Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses the importance of the RESONATE-2 Tri...
Author: ASHReport
Added: 12/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Precautions and Suggestions Regarding Management of Adverse Events of BCR Signaling Inhibitors
Nitin Jain, M.D. Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses Precautions and Suggestions Regardin...
Author: ASHReport
Added: 12/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2015 Category: Cancer & Oncology Source Type: podcasts
MD Anderson’s Real World Experience With BCR signaling Inhibitors in CLL
Nitin Jain, M.D. Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses MD Anderson’s Real World Experience ...
Author: ASHReport
Added: 12/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2015 Category: Cancer & Oncology Source Type: podcasts
End to Chemotherapy in CLL Most Likely as Targeted and Immunotherapy Move to Frontline
Nitin Jain, M.D. Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX discusses the nd to Chemotherapy in CLL Most L...
Author: ASHReport
Added: 12/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 11, 2015 Category: Cancer & Oncology Source Type: podcasts
How we use 3-D mammography
http://www.mdanderson.org/p...
The University of Texas MD Anderson Cancer Center began ...
Author: mdanderson
Added: 12/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - December 4, 2015 Category: Cancer & Oncology Source Type: podcasts
iwNHL 2015: Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical tria...
Author: VJHemOnc
Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts
Expert Perspective on Managing MPNs After Treatment Loses Its Effectiveness
Can MPN patients develop biological markers that influence their current therapies? Yes, says MPN expert Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center. Dr. Verstovsek dis...
Author: P2Professional
Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2015 Category: Cancer & Oncology Source Type: podcasts
Deciphering the Evolution of CLL Therapeutics
Fresh from the iwCLL, CLL expert Dr. William Plunkett, Professor in the Department of Experimental Therapeutics at The University of Texas MD Anderson Cancer Center shares the latest news on CLL thera...
Author: P2Professional
Added: 11/20/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2015 Category: Cancer & Oncology Source Type: podcasts
